Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Research Report 2012-2023

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

1.1.2 Specifications

1.2 Market Segment

1.2.1 by Type

1.2.1.1 CMX-020

1.2.1.2 CA-016

1.2.1.3 DD-04107

1.2.1.4 Others

1.2.2 by Application

1.2.2.1 Ophthalmology

1.2.2.2 Immunology

1.2.2.3 Muscle Spasm

1.2.2.4 Pruritus

1.2.2.5 Abdominal Pain

1.2.2.6 Others

1.2.3 by Regions

2 Industry Chain

2.1 Industry Chain Structure

2.2 Upstream

2.3 Market

2.3.1 SWOT

2.3.2 Dynamics

3 Environmental Analysis

3.1 Policy

3.2 Economic

3.3 Technology

3.4 Market Entry

4 Market Segmentation by Type

4.1 Market Size

4.1.1 CMX-020 Market, 2012-2017

4.1.2 CA-016 Market, 2012-2017

4.1.3 DD-04107 Market, 2012-2017

4.1.4 Others Market, 2012-2017

4.2 Market Forecast

4.2.1 CMX-020 Market Forecast, 2018-2023

4.2.2 CA-016 Market Forecast, 2018-2023

4.2.3 DD-04107 Market Forecast, 2018-2023

4.2.4 Others Market Forecast, 2018-2023

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Ophthalmology Market, 2012-2017

5.1.2 Immunology Market, 2012-2017

5.1.3 Muscle Spasm Market, 2012-2017

5.1.4 Pruritus Market, 2012-2017

5.1.5 Abdominal Pain Market, 2012-2017

5.1.6 Others Market, 2012-2017

5.2 Market Forecast

5.2.1 Ophthalmology Market Forecast, 2018-2023

5.2.2 Immunology Market Forecast, 2018-2023

5.2.3 Muscle Spasm Market Forecast, 2018-2023

5.2.4 Pruritus Market Forecast, 2018-2023

5.2.5 Abdominal Pain Market Forecast, 2018-2023

5.2.6 Others Market Forecast, 2018-2023

6 Market Segmentation by Region

6.1 Market Size

6.1.1 Asia-Pacific

6.1.1.1 Asia-Pacific Market, 2012-2017

6.1.1.2 Asia-Pacific Market by Type

6.1.1.3 Asia-Pacific Market by Application

6.1.2 North America

6.1.2.1 North America Market, 2012-2017

6.1.2.2 North America Market by Type

6.1.2.3 North America Market by Application

6.1.3 Europe

6.1.3.1 Europe Market, 2012-2017

6.1.3.2 Europe Market by Type

6.1.3.3 Europe Market by Application

6.1.4 South America

6.1.4.1 South America Market, 2012-2017

6.1.4.2 South America Market by Type

6.1.4.3 South America Market by Application

6.1.5 Middle East & Africa

6.1.5.1 Middle East & Africa Market, 2012-2017

6.1.5.2 Middle East & Africa Market by Type

6.1.5.3 Middle East & Africa Market by Application

6.2 Market Forecast

6.2.1 Asia-Pacific Market Forecast, 2018-2023

6.2.2 North America Market Forecast, 2018-2023

6.2.3 Europe Market Forecast, 2018-2023

6.2.4 South America Market Forecast, 2018-2023

6.2.5 Middle East & Africa Market Forecast, 2018-2023

7 Market Competitive

7.1 Global Market by Vendors

7.2 Market Concentration

7.3 Price & Factors

7.4 Marketing Channel

8 Major Vendors

8.1 Amgen Inc

8.1.2 Profile

8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.2 Amorepacific Corp

8.2.1 Profile

8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.3 BCN Peptides SA

8.3.1 Profile

8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.4 Centrexion Therapeutics Corp

8.4.1 Profile

8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.5 Daewoong Pharmaceutical Co Ltd

8.5.1 Profile

8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.6 DoNatur GmbH

8.6.1 Profile

8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.7 Flex Pharma Inc

8.7.1 Profile

8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.8 Grunenthal GmbH

8.8.1 Profile

8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.9 Kyowa Hakko Kirin Co Ltd

8.9.1 Profile

8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.10 Medifron DBT Co Ltd

8.10.1 Profile

8.10.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.11 Neurim Pharmaceuticals Ltd

8.12 Pila Pharma AB

8.13 Sylentis SAU

8.14 Toray Industries Inc

8.15 Vitality Biopharma Inc

9 Conclusion

Table Products Segment of Transient Receptor Potential Cation Channel Subfamily V Member 1

Table CMX-020 Overview

Table CA-016 Overview

Table DD-04107 Overview

Table Others Overview

Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Type, 2011-2022 (USD Million)

Table Application Segment of Transient Receptor Potential Cation Channel Subfamily V Member 1

Table Ophthalmology Overview

Table Immunology Overview

Table Muscle Spasm Overview

Table Pruritus Overview

Table Abdominal Pain Overview

Table Others Overview

Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Application, 2011-2022 (USD Million)

Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Region, 2011-2022 (USD Million)

Table Cost of Transient Receptor Potential Cation Channel Subfamily V Member 1

Table Market Dynamics

Table Policy of Transient Receptor Potential Cation Channel Subfamily V Member 1

Table GDP of Major Countries

Table CMX-020 CAGR by Revenue and Volume, 2012-2017

Table CA-016 CAGR by Revenue and Volume, 2012-2017

Table DD-04107 CAGR by Revenue and Volume, 2012-2017

Table Others CAGR by Revenue and Volume, 2012-2017

Table CMX-020 CAGR by Revenue and Volume, 2012-2022

Table CA-016 CAGR by Revenue and Volume, 2012-2022

Table DD-04107 CAGR by Revenue and Volume, 2012-2022

Table Others CAGR by Revenue and Volume, 2012-2022

Table Ophthalmology CAGR by Revenue and Volume, 2012-2017

Table Immunology CAGR by Revenue and Volume, 2012-2017

Table Muscle Spasm CAGR by Revenue and Volume, 2012-2017

Table Pruritus CAGR by Revenue and Volume, 2012-2017

Table Abdominal Pain CAGR by Revenue and Volume, 2012-2017

Table Others CAGR by Revenue and Volume, 2012-2017